• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab.

作者信息

Hočevar Alojzija, Kopač Peter, Rotar Žiga, Novljan Martina Plešivčnik, Škrgat Sabina

机构信息

Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.

出版信息

J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2448-2449. doi: 10.1016/j.jaip.2020.04.006. Epub 2020 Apr 15.

DOI:10.1016/j.jaip.2020.04.006
PMID:32304835
Abstract
摘要

相似文献

1
Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab.在用贝那利珠单抗治疗严重嗜酸性粒细胞性哮喘期间，嗜酸性肉芽肿性多血管炎的病情进展
J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2448-2449. doi: 10.1016/j.jaip.2020.04.006. Epub 2020 Apr 15.
2
Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis.贝那利珠单抗作为嗜酸性肉芽肿性多血管炎严重哮喘的糖皮质激素节省治疗选择。
J Allergy Clin Immunol Pract. 2020 Oct;8(9):3225-3227.e2. doi: 10.1016/j.jaip.2020.05.033. Epub 2020 Jun 4.
3
Benralizumab as a Potential Adjunctive Therapy in Eosinophilic Granulomatosis With Polyangiitis.贝那利珠单抗作为嗜酸性肉芽肿性多血管炎的潜在辅助治疗药物。
J Clin Rheumatol. 2021 Dec 1;27(8S):S401-S402. doi: 10.1097/RHU.0000000000001419.
4
Benralizumab in eosinophilic granulomatosis with polyangiitis.贝那利珠单抗治疗嗜酸性肉芽肿性多血管炎
Med Clin (Barc). 2022 May 13;158(9):441-442. doi: 10.1016/j.medcli.2021.07.017. Epub 2021 Oct 30.
5
Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis.成功使用 benralizumab 治疗嗜酸性肉芽肿性多血管炎伴嗜酸性粒细胞性心肌炎。
Clin Exp Rheumatol. 2021 Oct;40(4):834-837. doi: 10.55563/clinexprheumatol/ahyqld. Epub 2022 May 4.
6
[Benralizumab in cases of eosinophilic granulomatosis with polyangiitis].[贝那利珠单抗用于嗜酸性肉芽肿性多血管炎病例]
Rev Mal Respir. 2022 Sep;39(7):621-625. doi: 10.1016/j.rmr.2022.06.004. Epub 2022 Jul 29.
7
Eosinophilic granulomatosis with polyangiitis successfully treated with benralizumab.使用贝那利珠单抗成功治疗嗜酸性肉芽肿性多血管炎。
Ann Allergy Asthma Immunol. 2020 Aug;125(2):228-230. doi: 10.1016/j.anai.2020.05.002. Epub 2020 May 11.
8
Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma.一名接受白细胞介素-5通路抑制剂治疗严重哮喘的患者发生了嗜酸性肉芽肿性多血管炎。
Rheumatology (Oxford). 2021 Feb 1;60(2):e59-e60. doi: 10.1093/rheumatology/keaa572.
9
Benralizumab: A novel treatment for the cutaneous features of paediatric eosinophilic granulomatosis with polyangiitis (pEGPA).贝那鲁肽：治疗儿童嗜酸性肉芽肿伴多血管炎（pEGPA）皮肤表现的一种新方法。
Australas J Dermatol. 2023 Aug;64(3):404-407. doi: 10.1111/ajd.14081. Epub 2023 May 17.
10
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis.贝那鲁肽对伴有嗜酸性粒细胞肉芽肿伴多血管炎的严重嗜酸性粒细胞性哮喘加重的快速作用。
BMC Pulm Med. 2021 Jan 21;21(1):35. doi: 10.1186/s12890-021-01397-7.

引用本文的文献

1
Eosinophilic granulomatosis with polyangiitis developed during treatment with benralizmab for severe asthma: A case report and literature review.在用贝那利单抗治疗重度哮喘期间发生嗜酸性肉芽肿性多血管炎：一例报告及文献综述
Respirol Case Rep. 2024 Jul 9;12(7):e01431. doi: 10.1002/rcr2.1431. eCollection 2024 Jul.
2
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database.重度哮喘生物疗法的安全性：对世界卫生组织药物警戒数据库中报告的疑似不良反应的分析。
BioDrugs. 2024 May;38(3):425-448. doi: 10.1007/s40259-024-00653-6. Epub 2024 Mar 15.
3
Dupilumab suppresses relapsing chronic eosinophilic pneumonia with severe asthma.
度普利尤单抗抑制伴有严重哮喘的复发性慢性嗜酸性粒细胞性肺炎。
Nagoya J Med Sci. 2023 Nov;85(4):857-865. doi: 10.18999/nagjms.85.4.857.
4
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics.抗中性粒细胞胞浆抗体阴性嗜酸性粒细胞肉芽肿性多血管炎：仅有嗜酸性粒细胞而无血管炎？抗 T2 生物制剂的新见解。
Front Immunol. 2023 Nov 27;14:1325299. doi: 10.3389/fimmu.2023.1325299. eCollection 2023.
5
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.美泊利单抗和贝那利珠单抗治疗重度嗜酸性粒细胞性哮喘及嗜酸性肉芽肿性多血管炎的“超级应答者”的真实世界特征
ERJ Open Res. 2023 Oct 30;9(5). doi: 10.1183/23120541.00419-2023. eCollection 2023 Sep.
6
New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors.2例患者在使用IL-5通路抑制剂治疗期间发生新发嗜酸性肉芽肿性多血管炎。
Immunol Res. 2022 Dec;70(6):721-724. doi: 10.1007/s12026-022-09317-5. Epub 2022 Sep 20.
7
Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis.贝那利珠单抗治疗嗜酸性肉芽肿性多血管炎疗效的观点
Front Pharmacol. 2022 Mar 10;13:865318. doi: 10.3389/fphar.2022.865318. eCollection 2022.
8
Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab.重度哮喘患者在停用度普利尤单抗后出现嗜酸性肉芽肿性多血管炎。
Intern Med. 2022 Mar 1;61(5):755-759. doi: 10.2169/internalmedicine.7990-21. Epub 2021 Aug 13.
9
Emergence of extrathoracic manifestations of eosinophilic granulomatosis with polyangiitis during benralizumab treatment.在贝那利珠单抗治疗期间，嗜酸性肉芽肿性多血管炎出现胸外表现。
Rheumatol Adv Pract. 2021 May 1;5(2):rkab033. doi: 10.1093/rap/rkab033. eCollection 2021.